Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Somatic gene therapy for phenylketonuria and other hepatic deficiencies.
[classical phenylketonuria]
Gene
therapy
is
the
delivery
of
genetic
material
to
specific
cell
types
of
an
organism
to
alter
its
physiology
or
function
.
This
technology
is
being
explored
as
a
means
of
treating
diseases
caused
by
deficiencies
of
hepatic
gene
products
.
The
two
diseases
being
used
as
models
for
hepatic
gene
therapy
are
classical
phenylketonuria
(
PKU
)
and
haemophilia
B
.
Vectors
derived
from
adenoviruses
can
be
used
to
completely
correct
these
diseases
in
animal
models
.
The
phenotypic
correction
generated
in
these
studies
is
transient
,
and
can
not
be
duplicated
by
vector
readministration
.
The
transient
nature
of
transgene
expression
results
from
the
destruction
of
the
virally-transduced
cells
by
a
cellular
immune
response
directed
against
the
late
viral
gene
products
that
are
also
expressed
in
the
target
cells
.
The
inability
to
repeatedly
administer
virus
is
caused
by
a
humoral
immune
response
directed
against
viral
proteins
present
at
the
time
of
infusion
.
If
the
host
immune
response
is
suppressed
,
transgene
expression
can
persist
for
6
months
or
more
.
These
findings
suggest
that
host
immunomodulation
in
combination
with
further
modification
of
the
adenoviral
vector
to
reduce
or
eliminate
late
viral
gene
expression
may
permit
long
-term
expression
of
potentially
therapeutic
gene
products
in
mammalian
liver
.
Diseases
Validation
Diseases presenting
"a humoral immune response directed against viral proteins present at the time of infusion"
symptom
classical phenylketonuria
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom